KRAS4A directly regulates hexokinase 1

Area of Science:

• Molecular biology
• Oncology
• Cellular metabolism

Background:

• KRAS is a frequently mutated oncogene in cancer, producing KRAS4A and KRAS4B isoforms with distinct C-terminal regions.
• Oncogenic KRAS mutations activate cellular transformation and alter tumor cell metabolism, notably inducing the Warburg effect.
• Previous studies attributed metabolic alterations to transcriptional changes, with direct enzyme regulation remaining unclear.

Purpose of the Study:

• To investigate potential direct interactions between KRAS isoforms and metabolic enzymes.
• To establish whether KRAS4A directly regulates metabolic enzyme activity.
• To explore the functional and therapeutic implications of KRAS4A-mediated metabolic regulation.

Main Methods:

• Biochemical assays to detect GTP-dependent interactions between KRAS4A and hexokinase 1 (HK1).
• Cellular localization studies to examine the colocalization of KRAS4A and HK1 on the outer mitochondrial membrane.
• Functional assays to assess the impact of the KRAS4A-HK1 interaction on HK1 activity.

Main Results:

• A direct, GTP-dependent interaction was identified between KRAS4A and hexokinase 1 (HK1).
• This interaction was shown to directly alter the enzymatic activity of HK1, establishing HK1 as an effector of KRAS4A.
• The unique palmitoylation cycle of KRAS4A facilitates its colocalization with HK1 on the outer mitochondrial membrane.

Conclusions:

• KRAS4A directly regulates HK1 activity, representing a novel mechanism of metabolic control in cancer.
• The KRAS4A-HK1 interaction highlights isoform-specific functions of KRAS in cancer metabolism.
• Targeting the KRAS4A-HK1 interaction may exploit unique metabolic vulnerabilities in KRAS4A-expressing cancers for therapeutic benefit.